Bohai's Products.
Our medicines are intended to address rheumatoid arthritis, viral infections, gynecological diseases, cardiovascular issues and respiratory diseases. We obtained Drug Approval Numbers for 29 varieties of traditional Chinese herbal medicines in 2004 and currently produce 10 varieties of approved traditional Chinese herbal medicines in seven delivery systems: tablets, granules, capsules, syrup, concentrated powder, tincture and medicinal wine. Of these 10 products 4 are prescription drugs and 6 are over-the-counter, or OTC, products. In a significant development, on December 1, 2009, Bohai’s lead products, Tongbi Capsules and Tablets and Lung Nourishing Cream, became eligible for reimbursement under China’s National Medical Insurance Program.
Contact Bohai.
For all inquiries, including company management directors and investor relations, please contact:
Trilogy Capital Partners
Darren Minton, President
800.592.6067 Toll Free
info@trilogy-capital.com
156 W. 56th Street, Suite 1605
New York, NY 10019 USA
http://www.trilogy-capital.com
